Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Michigan Advanced Psychiatry pioneers FDA-approved neuromodulation therapies like TMS, IV ketamine, and Spravato to treat resistant mental health conditions, offering fast, effective alternatives for ...

Am J Psych：一种实验性的SAINT抑郁症疗法或能有效治疗近80%的抑郁症患者！ SAINT 抑郁症 疗法 磁脉冲定位 神经回路 来源：本站原创 2021-11-09 21:50 来自 ...

Understanding mental illness requires understanding psychiatric disorder causality. New brain research explores this in ...

Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.

A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com. About CVRx, Inc. CVRx is a commercial-stage medical ...

The Science & PINS Prize for Neuromodulation is a highly competitive award that recognizes scientists for their outstanding contributions in neuromodulation research. Neuromodulation is any form of ...

However, neuromodulation doesn’t directly act on weights. Rather, it alters how likely a neuron or network is to be capable of changing their connection—that is, their flexibility. Neuromodulation is ...

The current neuromodulation market has an estimated value of $5.8 billion, with over 50% of the value given by the SCS sector.